Our scleroderma skin grafts to humanized mice support IL-6 trans-signaling as a key driver of skin fibrosis in pansclerotic morphea and align our results with recent identification of STAT4 mutations driving IL-6 expression in the childhood form of pansclerotic morphea (4). Here, IL6 is linked to scleroderma.